Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Photo: John Beckmann/BSR Agency/Getty Images
The European Medicines Agency on Wednesday recommended Moderna's coronavirus vaccine for authorization in the European Union's 27 member states.
Why it matters: This is the second vaccine to be granted approval by the regulator. The European Commission — which has purchased 160 million doses of the Moderna vaccine — is likely to issue final approval this week.
- European Commission President Ursula von der Leyen tweeted that they "are working at full speed to approve it & make it available in the EU."
- The commission approved the Pfizer-BioNTech vaccine in December.
The big picture: The EU has been criticized for its slow rollout of the vaccine as cases continue to rise and countries enter a third wave of lockdowns.
- The EU officially began vaccinating with Pfizer-BioNTech shots on Dec. 27, but each country's distribution has been different.
- According to CNBC, Germany vaccinated about 240,000 people in the first week of EU approval, while France inoculated 516 people and the Netherlands had not even started vaccinating.
- The approval of the Moderna vaccine should further help the EU and its 446 million inhabitants resolve some supply issues.
What they're saying: "EMA’s human medicines committee (CHMP) has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and recommended by consensus a formal conditional marketing authorisation be granted by the European Commission," EMA said in its statement.